The domestic equity indices ended the last trading on a high. BSE Sensex ended 418 points higher, while Nifty gained 114 points. Today, both indices...
Ahmedabad-headquartered pharmaceutical company Zydus Lifesciences announced on Tuesday that it has received approval for manufacturing and marketing a generic version of Varenicline tablets from the...
Shares of Zydus Lifesciences were trading in the early hours of March 22, after the company’s subsidiary received USFDA approval for tofacitinib tablets. Zydus Pharmaceuticals...
On Monday, Zydus Lifesciences said it received the USFDA’s (United States Food and Drug Administration) final nod to market its version of Mirabegron extended-release tablets...
On Monday, Zydus Lifesciences said that it had received final approval from US health regulators to market its antacid famotidine tablets in the US market....
Zydus Lifesciences announced that the safety and efficacy analysis data from the phase-III clinical trial of its Covid-19 vaccine ZyCoV-D has been examined and published...
Zydus Lifesciences said its subsidiary had acquired US-based BridgeBio Pharma. Sentynl Therapeutics, a subsidiary of Zydus Lifesciences and BridgeBio Pharma, have done an asset purchase...